Skip to main content
. 2019 May 14;44:250–260. [Article in Spanish] doi: 10.1016/j.ebiom.2019.05.010

Fig. 3.

Fig. 3

Significant survival differences for four cohorts. (a) TCGA cohort, (b) LIRI-JP cohort, (c) NCI cohort, (d) E-TABM-36 cohort. S1: aggressive (higher-risk survival) subtype; S2: moderate (lower-risk survival) subtype.